60
Participants
Start Date
April 1, 2024
Primary Completion Date
August 15, 2025
Study Completion Date
September 15, 2025
Semaglutide
Solution for subcutaneous (s.c. - under the skin) injection. 0.25 mg semaglutide once weekly for four weeks, 0.5 mg semaglutide once weekly for four weeks, 0.1 mg semaglutide once weekly for four weeks, 1.7 mg semaglutide once weekly for four weeks followed by 2.4 mg semaglutide once weekly for eight weeks
Placebo
Solution for subcutaneous (s.c. - under the skin) injection
RECRUITING
Shenzhen Institute of Advanced Technology, Shenzhen
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
OTHER